Physician profile
Taylor E Rossow
NPI 1235591199
$3,454.98
in general payments reported to CMS, 2019-2025
20 companies · $816 in 2025
The $816 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $435 · 2021: $755 · 2022: $646 · 2023: $81.15 · 2024: $385 · 2025: $816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,281.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,140.74 | 2019-2025 | Clareon, Tryptyr, Clareon Panoptix Pro |
| Sun Pharmaceutical Industries INC. | $795.84 | 2020-2025 | |
| Abbvie INC. | $238.90 | 2022-2025 | |
| New World Medical,INC. | $210.15 | 2020-2025 | Clearpath, Ahmed Glaucoma Valve, Streamline |
| Amgen INC. | $147.79 | 2024-2025 | Tepezza |
| Allergan, INC. | $131.54 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $114.08 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $93.55 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $89.73 | 2022-2025 | Vyzulta, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $89.10 | 2020-2021 | |
| Biotissue Holdings INC. | $86.48 | 2022 | |
| Harrow Eye, LLC | $62.22 | 2024-2025 | Vevye, Iheezo |
| Oyster Point Pharma, INC. | $60.51 | 2022-2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $43.91 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $40.59 | 2023-2024 | Rayone Aspheric, Rayone Spheric, Omidria |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $38.05 | 2021 | |
| Mallinckrodt Hospital Products INC. | $27.93 | 2022 | |
| Glaukos Corporation | $17.36 | 2023 | |
| Dompe US, INC. | $13.92 | 2022 | |
| Sight Sciences, INC. | $12.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Rossow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.